Brain barrier breakthrough tested for Alzheimer's
NCT ID NCT05469009
Summary
This early study is testing whether temporarily opening the protective blood-brain barrier with a focused ultrasound device is safe and feasible when combined with standard Alzheimer's drug infusions. It involves 15 people with mild Alzheimer's or mild cognitive impairment. The goal is to see if this approach helps more of the drug reach the brain and potentially slow disease progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West Virginia University Rockefeller Neuroscience Institute
Morgantown, West Virginia, 26506, United States
Conditions
Explore the condition pages connected to this study.